Issued Patents All Time
Showing 1–25 of 27 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11845990 | Prediction of sleep parameter and response to sleep-inducing compound based on PER3 VNTR genotype | Mihael H. Polymeropoulos, Gunther Birznieks | 2023-12-19 |
| 11737993 | Multiple myeloma treatment | Mihael H. Polymeropoulos, Louis William Licamele | 2023-08-29 |
| 11667718 | Cancer treatment | Mihael H. Polymeropoulos, Louis William Licamele | 2023-06-06 |
| 11458154 | Treatment of CYR61- and VEGF-mediated conditions | Mihael H. Polymeropoulos, Louis William Licamele | 2022-10-04 |
| 11266622 | Method of treatment | Mihael H. Polymeropoulos | 2022-03-08 |
| 11078289 | Cancer treatment | Mihael H. Polymeropoulos, Louis William Licamele | 2021-08-03 |
| 11060144 | Prediction of sleep parameter and response to sleep-inducing compound based on PER3 VNTR genotype | Mihael H. Polymeropoulos, Gunther Birznieks | 2021-07-13 |
| 10653665 | Method of treatment | Mihael H. Polymeropoulos | 2020-05-19 |
| 10570452 | Method of predicting a predisposition to QT prolongation | Simona Volpi, Louis William Licamele | 2020-02-25 |
| 10570453 | Method of predicting a predisposition to QT prolongation | Simona Volpi, Louis William Licamele, Kendra Tomino Mack, Callie Michelle Heaton | 2020-02-25 |
| 10563260 | Method of predicting a predisposition to QT prolongation | Simona Volpi, Louis William Licamele | 2020-02-18 |
| 10563261 | Method of predicting a predisposition to QT prolongation | Simona Volpi, Louis William Licamele | 2020-02-18 |
| 10265282 | Cancer treatment | Mihael H. Polymeropoulos, Louis William Licamele | 2019-04-23 |
| 10179119 | Method of treatment | Mihael H. Polymeropoulos | 2019-01-15 |
| 9458507 | Antipsychotic treatment based on SNP genotype | Simona Volpi, Louis William Licamele, Mihael H. Polymeropoulos | 2016-10-04 |
| 9408839 | Antipsychotic treatment based on DRD2 or ANKK1 SNP genotype | Simona Volpi | 2016-08-09 |
| 9328387 | Antipsychotic treatment based on SNP genotype | Simona Volpi, Louis William Licamele, Mihael H. Polymeropoulos | 2016-05-03 |
| 9243295 | Antipsychotic treatment based on DRD2 or ANKK1 SNP genotype | Simona Volpi | 2016-01-26 |
| 9080214 | Genetic markers for efficacy of iloperidone in the treatment of psychotic symptoms | Simona Volpi, Louis William Licamele, Mihael H. Polymeropoulos | 2015-07-14 |
| 9074254 | Method of predicting a predisposition to QT prolongation | Simona Volpi, Louis William Licamele, Kendra Tomino Mack, Callie Michelle Heaton | 2015-07-07 |
| 9072742 | Method of predicting a predisposition to QT prolongation | Simona Volpi, Louis William Licamele | 2015-07-07 |
| 9074255 | Method of predicting a predisposition to QT prolongation | Simona Volpi, Louis William Licamele | 2015-07-07 |
| 9074256 | Method of predicting a predisposition to QT prolongation | Simona Volpi, Louis William Licamele | 2015-07-07 |
| 9057104 | Antipsychotic treatment based on DRD2 or ANKK1 SNP genotype | Simona Volpi | 2015-06-16 |
| 8865210 | Stable dosage formulations of imidazolylalkyl-pyridines | Deepak Phadke | 2014-10-21 |